Growth in first year appears unaffected by prenatal SSRI use

03/20/2013 | HealthDay News

Taking selective serotonin reuptake inhibitors during pregnancy may not affect an infant's growth during the first year of life, according to a study published online in the American Journal of Psychiatry. Researchers found that babies born to mothers who took the antidepressants had comparable weight, length and head circumference as babies with no exposure to the drugs.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT